MBX logo

Microbix Biosystems Inc. Stock Price

TSX:MBX Community·CA$33.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MBX Share Price Performance

CA$0.24
-0.11 (-31.43%)
CA$0.24
-0.11 (-31.43%)
Price CA$0.24

MBX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

1 Risk
1 Reward

Microbix Biosystems Inc. Key Details

CA$21.1m

Revenue

CA$9.3m

Cost of Revenue

CA$11.8m

Gross Profit

CA$12.1m

Other Expenses

-CA$324.8k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0023
55.77%
-1.54%
16.5%
View Full Analysis

About MBX

Founded
1988
Employees
n/a
CEO
Cameron Groome
WebsiteView website
www.microbix.com

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Recent MBX News & Updates

Subdued Growth No Barrier To Microbix Biosystems Inc.'s (TSE:MBX) Price

Nov 21
Subdued Growth No Barrier To Microbix Biosystems Inc.'s (TSE:MBX) Price

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Aug 15
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Recent updates

No updates